Vicente H. Gracias appointed Senior Vice Chancellor for Clinical Affairs

Dear Members of the RBHS Community:

I am pleased to announce that Vicente H. Gracias, MD has been selected to serve as senior vice chancellor for clinical affairs for Rutgers Biomedical and Health Sciences (RBHS).

Reporting directly to me, Dr. Gracias will serve as the chief clinical officer of RBHS and lead the growth and evolution of our clinical enterprise during this time of systemic change in health care. Dr. Gracias will work closely with our clinical deans, institute directors, and faculty leaders to encourage collaboration, advance quality and excellence, and provide strategic direction. With his characteristic energy and enthusiasm, Dr. Gracias will be our champion for adopting the paradigm of patient-centered, population-based, and value-driven health care practices throughout RBHS, the university, and surrounding health systems. He will also serve as a liaison with the principal teaching hospitals of RBHS, insurers and payers, and our patient communities.

Dr. Gracias recently served as interim dean of the Robert Wood Johnson Medical School (RWJMS) where he helped orchestrate its successful start toward value driven care. He is also a professor of surgery and founded the surgical critical care and acute care surgery fellowships at RWJMS. Fellowship trained and board certified in general surgery, trauma surgery, and surgical critical care, he has served as chief of acute care surgery and as the director of both the adult and pediatric trauma centers at Robert Wood Johnson University Hospital. Dr. Gracias received his undergraduate degree from the University of Notre Dame and his MD from the University of Utah School of Medicine. He completed residency training in general surgery at the University of Illinois in Chicago, Metro Group Hospitals, and fellowship in trauma/surgical critical care at the University of Pennsylvania (Penn) Medical Center.

Following an internal search, Dr. Gracias was selected from a pool of talented clinical leaders from across RBHS. Faculty submitted nominations of qualified candidates and the RBHS clinical deans and institute directors provided advice and counsel. A slate of three finalists were presented and interviewed by me.

Please join me in congratulating Dr. Gracias on this new role and an important step forward for RBHS as we develop Rutgers University’s clinical enterprise to best serve our patients, students, and the residents of New Jersey and to be among the premier academic health centers in the nation.


Brian L. Strom, MD, MPH